← Back to catalogue

Vysis

FDA UDI

Class II (US FDA UDI)

by Abbott Molecular

Identity

Trade Name
Vysis FDA UDI
Generic Name
Acute myeloid leukaemia (AML) genetic mutation IVD, probe FDA UDI
Device Name
Vysis D7S486/CEP 7 FISH Probe Kit FDA UDI
Model / Reference
04N78-020 FDA UDI
Description
Vysis D7S486/CEP 7 FISH Probe Kit FDA UDI

Identifiers

Catalog Number
04N78-020 FDA UDI
Primary DI / UDI-DI
00884999036406 FDA UDI
510(k) Number
K131508 FDA UDI
FDA Product Code
PFG FDA UDI
GMDN Term
Acute myeloid leukaemia (AML) genetic mutation IVD, probe FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.1870 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Acute myeloid leukaemia (AML) genetic mutation IVD, probe

Vysis by Abbott Molecular — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Acute myeloid leukaemia (AML) genetic mutation IVD, probe.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Abbott Molecular

Sources (1)

  • FDA UDI c86208ef-721d-402a-94b8-75b6d9521151 37 fields · synced May 31, 2026